Evidence map›Paper›PMID 20009032›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2010

Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist.

Meena Garg, Manikkavasagar Thamotharan, Gerald Pan, Paul W N Lee, Sherin U Devaskar

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Retinoic acid rescues alveolar hypoplasia in the calorie-restricted developing rat lung.American journal of respiratory cell and molecular biology · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Fetal origins of adult disease.Current problems in pediatric and adolescent health care · 2011
    Review
  17. Childhood obesity and environmental chemicals.The Mount Sinai journal of medicine, New York
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Meena GargNeonatal Research Center, Department of Pediatrics, David Geffen School of Medicine University of California Los Angeles, USA.
Manikkavasagar Thamotharan
Gerald Pan
Paul W N Lee
Sherin U Devaskar
University of California, Los Angeles · USHarbor–UCLA Medical Center · US

Funding

Prenatal Metabolic Programming of the OffspringR01HD041230 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 2001 to 2019
$5.2M
POSTNATAL ASPECTS OF A GLUCOSE TRANSPORTERR01HD033997 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 1995 to 2008
$3.1M
PERINATAL METABOLIC AND HORMONAL EFFECTSR01HD025024 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 1996 to 2010
$2.6M
Role of Placental Transport In Fetal GrowthR01HD046979 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 2004 to 2008
$1.7M
DEVELOPMENTAL REGULATION OF NEURON INSULIN-LIKE PEPTIDER29HD025024 · NICHD · SAINT LOUIS UNIVERSITY · PI DEVASKAR, SHERIN U. · 1989 to 1993
–
NICHD NIH HHS HD-046979NICHD NIH HHS HD-25024NICHD NIH HHS HD-33997NICHD NIH HHS HD-41230
6 · The paper itself

Abstract

Prenatal nutrient restriction with intrauterine growth restriction (IUGR) alters basal and glucose-stimulated insulin response and hepatic metabolic adaptation. The effect of early intervention with insulin-sensitizing peroxisome proliferator-activated receptor gamma agonists was examined in the metabolically maladapted F(1) pregestational IUGR offspring with a propensity toward pregnancy-induced gestational diabetes. The effect of rosiglitazone maleate [RG; 11 micromol/day from postnatal day (PN) 21 to PN60] vs. placebo (PL) on metabolic adaptations in 2-mo-old F(1) female rats subjected to prenatal (IUGR), postnatal (PNGR), or pre- and postnatal (IUGR + PNGR) nutrient restriction was investigated compared with control (CON). RG vs. PL had no effect on body weight or plasma glucose concentrations but increased subcutaneous white and brown adipose tissue and plasma cholesterol concentrations in all three experimental groups. Glucose tolerance tests with a 1:1 mixture of [2-(2)H(2)]- and [6,6-(2)H(2)]glucose in RG IUGR vs. PL IUGR revealed glucose tolerance with a lower glucose-stimulated insulin release (GSIR) and suppressed endogenous hepatic glucose production (HGP) with no difference in glucose clearance (GC) and recycling (GR). RG PNGR, although similar to PL CON, was hyperglycemic vs. PL PNGR with reduced GR but no difference in the existent low GSIR, HGP, and GC. RG IUGR + PNGR overall was no different from the PL counterpart. Insulin tolerance tests revealed perturbed recovery to baseline from the exaggerated hypoglycemia in RG vs. the PL groups with the only exception being RG PNGR where further worsening of hypoglycemia over PL PNGR was minimal with full recovery to baseline. These observations support that early intervention with RG suppressed HGP in IUGR vs. PL IUGR, without increasing GSIR similar to that seen in CON. Although RG reversed PNGR to the PL CON metabolic state, no such insulin-sensitizing effect was realized in IUGR + PNGR.

Indexed as

AnimalsAnimals, NewbornBlood GlucoseBody WeightDose-Response Relationship, DrugFemaleFetal Growth RetardationHumansPPAR gammaPregnancyPrenatal Exposure Delayed EffectsRatsRats, Sprague-DawleyRosiglitazoneThiazolidinedionesBlood GlucosePPAR gammaRosiglitazoneThiazolidinediones

Identifiers

PMID20009032
PMCPMC2838528
OpenAlexW2153768607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.